Javier de la Torre
Universitat Autònoma de Barcelona, Hospital Materno-Infantil
Papers
5
Total Citations
101
H-Index
5
About
Javier de la Torre is a leading gynecologic oncologist whose research has fundamentally advanced the surgical staging and management of endometrial, ovarian, and cervical cancers. His work focuses on refining minimally invasive techniques—particularly laparoscopic and robot-assisted approaches—to improve patient outcomes while reducing surgical morbidity. De la Torre is best known for his leadership in the STELLA trial program, a series of prospective randomized studies comparing transperitoneal versus extraperitoneal laparoscopic aortic lymphadenectomy. The landmark STELLA trial (27 citations) and its follow-up, STELLA-2, demonstrated that extraperitoneal access significantly reduces surgical complications, a finding reinforced by his post hoc analysis of robot-assisted approaches (15 citations). His work on surgical management of early-stage cervical cancer (25 citations) remains a key reference for clinicians, while his investigation into surgical approaches for endometrial cancer patients with BMI >35 kg/m² (18 citations) addresses a critical gap in care for this high-risk population. With over 100 cumulative citations across his most influential papers, de la Torre’s research has directly shaped clinical guidelines and operative standards, establishing him as a pivotal figure in evidence-based gynecologic oncology surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2The surgical management of early-stage cervical cancer25 citations · 2013
- 3
- 4
- 5